The Translation Evidence Mechanism. The Compact between Researcher and Clinician by Bauer, Janet G & Chiappelli, Francesco
  The Open Dentistry Journal, 2010, 4, 133-139 133 
 
  1874-2106/10  2010 Bentham Open 
Open Access 
The Translation Evidence Mechanism. The Compact between Researcher 
and Clinician 
Janet G. Bauer* and Francesco Chiappelli 
UCLA School of Dentistry, Division of Restorative Dentistry, June and Paul Ehrlich Endowed Program in Geriatric 
Dentistry, 23-008E CHS, PO Box 951668, 10833 Le Conte Avenue, Los Angeles, California 90095-1668, USA 
Abstract: Currently, best evidence is a concentrated effort by researchers. Researchers produce information and expect 
that clinicians will implement their advances in improving patient care. However, difficulties exist in maximizing coop-
eration and coordination between the producers, facilitators, and users (patients) of best evidence outcomes. The Transla-
tional Evidence Mechanism is introduced to overcome these difficulties by forming a compact between researcher, clini-
cian and patient. With this compact, best evidence may become an integral part of private practice when uncertainties 
arise in patient health status, treatments, and therapies. The mechanism is composed of an organization, central database, 
and decision algorithm. Communication between the translational evidence organization, clinicians and patients is through 
the electronic chart. Through the chart, clinical inquiries are made, patient data from provider assessments and practice 
cost schedules are collected and encrypted (HIPAA standards), then inputted into the central database. Outputs are made 
within a timeframe suitable to private practice and patient flow. The output consists of a clinical practice guideline that re-
sponds to the clinical inquiry with decision, utility and cost data (based on the “average patient”) for shared decision-
making within informed consent. This shared decision-making allows for patients to “game” treatment scenarios using 
personal choice inputs. Accompanying the clinical practice guideline is a decision analysis that explains the optimized 
clinical decision. The resultant clinical decision is returned to the central database using the clinical practice guideline. 
The result is subsequently used to update current best evidence, indicate the need for new evidence, and analyze the 
changes made in best evidence implementation. When updates in knowledge occur, these are transmitted to the provider 
as alerts or flags through patient charts and other communication modalities.  
INTRODUCTION 
Advances have been made in reasoning the value and ap-
plication of best evidence to patients and society. Current 
mechanisms include comparative effectiveness research 
(CER) and evidence-based research (EBR). While CER and 
EBD assist in reasoning individual health and treatment 
choices during shared-decision making with service provid-
ers, a mechanism to maximize cooperation and coordination 
between those who produce and those who apply evidence is 
lacking. The purpose of this article is to introduce the Trans-
lational Evidence Mechanism (TEM) that explains the de-
velopment of data, its transformation into best evidence, 
clinical relevance, and meaning in practice. For healthcare, 
this mechanism defines the compact between researcher (re-
search synthesis), clinician (clinical expertise, local long-
term monitoring and implementation of evidence), and pa-
tients (patient choice and compliance). Thus, TEM provides 
the essential components of the biological, behavioral, and 
social interventions involved in clinical decision-making 
related to health care delivery.  
TRANSLATIONAL EVIDENCE MECHANISM 
The Translational Evidence Mechanism (Fig. 1) explains 
the dynamic by which best evidence is transformed into con-  
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sumer choices; in the case of healthcare, providing needed 
analyses of differing health care and service options for pa-
tients in deciding the best clinical decision. The mechanism 
consists of 3 components: Translational Evidence Organiza-
tion, central database, and decision-making algorithm. The 
outcome of this mechanism is to provide end-users: patients 
or clients, with current, best evidence to make informed and 
optimal decisions regarding life choices, choices specific to 
any discipline in which consumer-based wants, needs, and 
desires are expressed. The product of such a system is typi-
cally called a clinical practice guideline (CPG). A CPG takes 
into account the probability (or odds ratio) of an event or 
events, the human preferences (expressed as values) attrib-
uted to these events, and their costs (benefits or trade-offs).  
TRANSLATIONAL EVIDENCE ORGANIZATION 
The Translational Evidence Organization develops, veri-
fies, maintains, and updates current, best evidence for service 
providers in their consultations with patients. Initially, inputs 
to the organization are made in the form of an inquiry. This 
inquiry results from uncertainties that may arise in consumer 
decision-making. The inquiry drives this organization to 
provide in real-time, effective and efficient decision-making; 
in other words, in a manner that demands current best evi-
dence for immediate decision-making in determining the 
optimal cost/benefit choice for the consumer. If best evi-
dence does not exist currently, the organization initiates an 
internal inquiry to develop new evidence based on con-
sumer-based wants, needs, and desires. 134    The Open Dentistry Journal, 2010, Volume 4  Bauer and Chiappelli 
The primary purpose of the Translational Evidence Or-
ganization is to arbitrate published evidence and, in its ab-
sence, identify research that needs to be conducted by orga-
nizational affiliates or the research community in producing 
needed data.  The Comparative and Translational Researcher 
(Translational Researcher) coordinates with IT Research and 
Development administrators to vest a central database with 
evidence. Resultant research data is then defined by tem-
plates when inputted into a central database. Similarly, best 
evidence is defined by templates of outputs. Both inputs and 
outputs may be stratified within the central database by geo-
graphic, discipline, population, and/or other categorical 
needs. Outputs consist of arbitrated decision data produced 
by quantitative researchers, utility data (attitudes, beliefs, 
and preferences of both providers and consumers) produced 
by qualitative researchers, and cost data. Arbitrated best evi-
dence meets the rigorous standards of statistical significance, 
the soundness and generalization of information or whether 
findings can be applied to similar patients in similar settings.  
Outputs are stated in terms of validity and reliability of study 
design to express confidence in providing best evidence. All 
are displayed in clinical practice guidelines. The CPG is the 
vehicle, or professional standard, that manages data for use 
in private practice. 
Additional post arbitrators of best evidence include the 
provider (clinician) and consumer (patient). The clinician is 
concerned with clinical significance; whether research find-
ings can be applied to individual patients. Dental clinicians, 
dentists, make judgments that may weight best evidence dif-
ferently from researchers. Initially, clinical significance of 
decision data is coordinated with dentists in validating clini-
cally national, regional, or local relevant best evidence. The 
dentist’s evaluation of clinical significance is used by the 
translational researcher to reject or modify the clinical prac-
tice guideline or to re-identify and conduct investigations 
that produce other clinically relevant data. Personal and pro-
fessional experiences, values and preferences, and appropri-
ate practices, as well as patient well-being, quality of life 
issues, and costs weigh heavily on whether best evidence is 
used in clinical decisions. Thus, dentists are able to predict 
clinical outcomes in weighing risks against benefits and 
costs for individual patients. Dentists may also make rele-
vant standards of care in their local practice and for specific 
patient population characteristics. These clinical validations 
are necessary to translate research data into clinically useful 
data for patient care. 
Clinical significance also addresses the importance of the 
evidence that takes into consideration the long-term multi-
faceted monitoring of evidence in the context of human be-
havior (patients). However, clinical significance may vary 
between dentists and between patients. This difference re-
sults because dentists, as well as patients, make judgments 
that weigh differently personal and professional experiences, 
values and preferences, and appropriate practices. In other 
words, judgments of risk and benefits vary because of differ-
ences in weights given to these variables, especially when 
costs are included in the decision-making. All is important 
for patients in accepting best evidence in their acquiring the 
highest level of cost effective services, either through fee-
for-service or as a defined benefit of their dental insurance 
plan. Thus, patients become the “conceptual subject” to 
which best evidence is applied and quantitative and qualita-
tive outcomes are measured. However, patients may be ad-
vocates or adversaries of evidence. Patients may also exert 
demands on evidence to meet specific, personal needs. They 
may exert influence on the development and application of 
knowledge that does not necessarily meet acceptance criteria 
of researchers and dentists, but serves a personal need. They 
may also exert pressure to deny the development and appli-
cation of knowledge that is contrary to their philosophical 
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beliefs. Even in the profession’s best efforts of informing 
patients with best evidence and using clinician expertise to 
communicate individualized, effective treatments, patients 
ultimately decide if treatment regimens are adhered to or 
rejected outright. Patient adherence, modification, or rejec-
tion of best evidence in treatment scenarios provides the 
translational researcher with its meaning in practice. The 
translational researcher uses these evaluations in updating 
clinically relevant data. These updates are processed using 
decision, Bayesian, and sensitivity analyses within the cen-
tral database.  
Thus, the translational researcher is the final arbiter of 
evidence. The translational researcher functions, simplisti-
cally, to translate basic research language into the language 
of the clinician and patient. In other words, basic research is 
assessed, evaluated, and disseminated to the clinician in a 
means usable for shared decision-making. The product of 
evidence-based dentistry is the published CPG. While there 
is no requirement that the published clinical practice guide-
line be implemented in private practice, dentists could use 
best evidence to offer their patients best practices in a state-
of-the-art organization and facility. This requires that den-
tists review and effect personal, behavioral changes to ac-
complish care and service advances.  
CENTRAL DATABASE 
The central database is the repository of evidence, orga-
nized and stored utilizing evidence-based research knowl-
edge management software (EBRsoftware). EBRsoftware [1] 
is maintained by information technologists and integrated 
within the electronic patient chart. Both health information 
technology and the Internet, as a vehicle for information 
technology, has become the most cost effective mode of in-
formation transfer [2, 3]. It is this inclusive and reciprocal 
participation of all decision makers that accomplishes im-
provements in clinical care. The structure of the central data-
base consists of a primary network. This primary network 
contains all vested evidence. The network may then be parti-
tioned into subordinate databases. Information is then fil-
tered and segregated per subspecialty information. Subspe-
cialty information is that best evidence used in specific 
populations, geographic locales: national, regional, specialty, 
and local secondary networks, specialty procedural treat-
ments, quality assurance, costs, and care delivery including 
facility or equipment improvements. These subspecialty da-
tabases may facilitate access based on frequency of usage.  
INITIATING THE MECHANISM 
During the examination appointment (initial or recall), 
the dentist interviews and assess the patient for h/her health 
and oral status. The information is inputted into the elec-
tronic chart. Once assessments have been completed and the 
evaluation process of needed services or maintenance regi-
mens begins, the dentist discusses with the patient treatment 
options in arriving at a treatment plan. If presenting condi-
tions, patient characteristics, and treatment outcomes are 
uncertain in their benefits and harms, then the dentist partici-
pates with the patient in shared decision-making to provide 
informed consent, assisting the patient in making the most 
optimal clinical decision that meets their needs and choice in 
accomplishing oral health care and wellness. Using EBR-
software, the dentist accesses a clinical input form through 
the electronic chart to assist in forming a clinical question 
regarding the treatment options and their outcomes.  The 
input template is based on the PICO question, a standardized 
format for initiating evidence-based research. The PICO in-
put form (Fig. 2) is completed by the dentist based on patient 
responses.  
 
Fig. (2). Clinical Question Input Template. 
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When submitted, the clinical input form will interact with 
the central database. Because this form is being sent through 
the electronic patient chart, patient histories, assessments, 
evaluations, and practice cost schedules are collected and all 
information is encrypted prior to integrating with the central 
database. This encryption uses technologies to insure secu-
rity, privacy, and uphold the requirements of HIPAA. 
Based on the query, the EBRsoftware manages relevant 
data to return decision and utility best evidence coordinated 
with practice cost schedules in a clinical practice guideline 
template (Fig. 3). The CPG is returned dated and specified as 
to expiration date of the evidence provided, the functional 
status (functionally independent, frail, or functionally de-
pendent) of the patient to which the evidence applies, and, if 
available, the significance (statistical and clinical), utility 
ranking, and meaning in practice of the evidence. Other vis-
ual aids include links to  "customize," changing the compo-
nents of the CPG to accommodate different choices or cor-
rect mistakes, and "Learn more," to exhibit the documenta-
tion that produced the CPG and its relevant bibliography. 
The returned CPG is interactive in that it provides stratified 
risk scenarios for high, equipoise, or low risk takers that may 
be accessed and "gamed" through a drop down menu. Basi-
cally, the CPG provides a minimum of two treatment scenar-
ios: treatment and no treatment with their respective outcome 
(best evidence) probabilities; if more options or comparisons 
of treatments have been requested through the clinical input 
form, then those will be displayed in their entirety. Along 
with this decision data, utilities of each outcome are pro-
vided. These utilities are based on a scale from 0 to 9, a 
standard scale used in utility research.  
With the patient's involvement, returned quantitative and 
qualitative best evidence is organized into decision, utility, 
and cost data for each possible option/outcome to assist in 
shared decision-making. If utility rankings, based on the "av-
erage patient," are not acceptable to the patient, these may be 
changed through drop down menus, reflecting personal pref-
erences, values, and beliefs regarding the presented out-
comes. Thus, the patient may change, or "game," rankings to 
compare and test different treatment scenarios in optimizing 
the clinical decision; or in other words, provide assessments 
to compare personal trade-offs between options with the "av-
erage patient." If so desired, the dentist may manipulate out-
come reimbursements to provide different cost outcomes. All 
changes are immediately recalculated to demonstrate differ-
ent treatment scenarios for enhanced informed consents. The 
objective of patient "gaming" is to optimize the clinical deci-
sion. Accompanying the CPG exhibit is the decision analysis 
statement. This statement provides a written interpretation or 
meaning of the treatment scenarios and their calculations 
(Fig. 4a, b, and c). 
The decision analysis of the CPG is done by: firstly, in-
terpreting for the patient the probability of the outcome; sec-
ondly, multiplying utility data by the probability of the out-
come in interpreting the service benefit to the patient; and 
thirdly, multiplying the probability of the outcome by the 
treatment cost in determining the economic choice difference 
between outcomes (not applicable in Fig. 5). With these 
analyses, the patient can determine h/hers optimal treatment 
option. The example decision analysis in Fig. (5) may appear 
absurd as a stand-alone decision. However on reflection, the 
information may be helpful in determining a patient’s access 
to dental services. The resultant patient analysis and optimal 
clinical decision is returned to the central database to be re-
trieved by translational researchers in developing new re-
search questions or modifying existing evidence. Having an 
efficient decision-making process has an additional benefit 
of involving private practice as a unit in clinical research 
without disrupting normal patient flow or care. Conversely, 
clinicians may compare local based practice norms, patient 
characteristics, and standards to those derived on a regional 
and national basis.  
 
Fig. (3). Clinical Practice Guideline. 
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Once processed, the results may be transferred to the cen-
tral repository, or central database. Within the central data-
base, probabilities are updated using Bayesian analyses. Sen-
sitivity analysis determines which components of the CPG 
have the greatest impact on the clinical decision. This analy-
sis may also determine the effects of changes in one of the 
components or two or more of the components of the CPG. 
Updates may then be sent back to the dentist in learning how 
patient decisions differ from the "average patient" in the 
practice locale or change over time. This reciprocation of 
evidence is done through the electronic chart. It is facilitated 
with alerts or flags to disseminate improvements in provider 
understanding of the patient, h/hers treatments, and care de-
livery.  
MEANING IN PRACTICE OF THE EVIDENCE 
Quantifying and qualifying the meaning of evidence be-
gins at follow-up assessment visits, periodic dental examina-
tions. For these assessment visits, the patient provides up-
dates to decision data through patient compliance and out-
 
Fig. (4a). Example of decision analysis using decision data. 
 
Fig. (4b). Example of decision analysis using utility data. 
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comes dependent on healthy lifestyles and wellness. Utility 
data is updated by patient preferences and value of the serv-
ices rendered or recommended maintenance regimens. With 
input from the dentist, the translational researcher uses these 
periodic assessments to update the CPG in identifying new 
areas of research or improving its usefulness in private prac-
tice through sensitivity analyses. Thus, the dentist acts as a 
conduit for the researcher in providing local data regarding 
patient choices, compliance, and treatment outcomes in up-
dating or producing new evidence.  
DECISION-MAKING ALGORITHM 
A decision-making algorithm assists decision-makers in 
managing a decision process. Similar to evidence-based re-
search, an algorithm provides a systematic understanding of 
decision strategy management. The basic structure of the 
algorithm is the decision tree. A decision tree is a visual rep-
resentation of instructions to approach and manage a com-
plex decision process. For healthcare algorithms, clinical 
practice guidelines become decision tree termini. An exam-
ple of a healthcare algorithm for older adults is the Clinical 
Decision Tree of Oral Health (Fig. 5) [4].  
The Clinical Decision Tree of Oral Health is used to as-
sist decision makers in making effective and efficacious de-
cisions regarding treatment options that best optimize treat-
ment selection, personal utilities, and goals in improving oral 
health. Likewise, a decision-making algorithm structures the 
 
Fig. (4c). Example of decision analysis interpreting the CPG using decision and utility data. 
 
Fig. (5). Hypotaxis of decision-making. 
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organization of evidence in the central database registry. It is 
by the decision-making algorithm that evidence is managed 
and stored. The structure of the algorithm is essential to re-
trieval of best evidence when an inquiry is received. It is this 
structure that constitutes the ordered progression of human 
decision-making concerning outcomes, their comparisons, 
and associated information to make inferences regarding 
preferences (values) and affected costs (benefits, or trade-
offs).  
SUMMMARY 
The Translational Evidence Mechanism is a compact be-
tween researcher, clinician, and patient in understanding best 
evidence as it applies to private practice. Since best evidence 
is used in informed consents regarding optimal treatment 
decisions, it must stand to scientific rigor, be clinically rele-
vant, and produce changes in patient behavior. Thus, best 
evidence requires 3 components for effective production, 
validation, administration, and continuous monitoring of new 
knowledge and technology. The Translational Evidence 
Mechanism accomplishes this using a central database and 
decision-making algorithm. Communication of best evidence 
from translational researcher to clinician and patient is 
through the electronic chart. During shared decision-making, 
patients are active participants in determining the inputs of 
their personal life experiences and preferences directly into 
decision-making. Clinicians act as skilled assessors of pa-
tient presenting conditions, facilitators in patients arriving at 
informed and individualized decisions for personal care that 
meets their lifestyles and behaviors. Both act as reciprocators 
in a process that updates and screens best evidence for its 
practical implementation in patient care and meaning to so-
cietal health agendas. In return, changes in best evidence is 
disseminated as alerts or flags in patient charts. Thus, the 
Translational Evidence Mechanism uses evidence-based 
research methodologies in optimizing interdisciplinary re-
sources for promoting oral health and preventing disease in 
individual patients by integrating best evidence, clinical ex-
perience and expertise, and patients in clinical decision-
making, best evidence validation, and practical implementa-
tion.  
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